LXRepair develops the first in vitro diagnostic tests based on the DNA Repair Enzyme Signature for the personalization of radiotherapy and chemotherapy.

heads

Sylvie SAUVAIGO

Thierry MAILLET

Investor

Gwenaël HAMON